About: Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell'Ad

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell'Ad Goto Sponge Distinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 January 1995

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в січні 1995 (uk) im Januar 1995 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en xineru de 1995 (ast) artikull shkencor i botuar më 01 janar 1995 (sq) scientific article published on 01 January 1995 (en)
publication date	wds:Q72377470-DD9D0E76-A867-4BEE-863D-A06AC3110134
publication date	1995-01-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q72377470-521A0F5C-B70E-473C-BB64-E56754FF8547
language of work or name	English
author name string	wds:Q72377470-0C6EAB39-2D62-411A-8CE5-D52FC6F2A7E9 wds:Q72377470-1328835A-BF90-45F2-A769-46A08C1669A2 wds:Q72377470-4C9F3E88-7F58-4810-B872-E1EB663D2EBA wds:Q72377470-4DE3359C-3004-4B46-ABE3-60960382B612 wds:Q72377470-5C1030D0-7C2A-4AAF-87A7-F55910C0FC37 wds:Q72377470-9128B8BB-ADF5-4DE9-B7FC-057962326FCF wds:Q72377470-987606BD-5C3E-4F45-A1C4-C5A8E8D61535 wds:Q72377470-A7A48073-BC2D-4DEA-845D-F3C9B79476E7 wds:Q72377470-A7BCDCD6-882D-4583-BDBF-EDEC979A3AAF wds:Q72377470-E54A7257-60CB-4BB6-8537-17AE61676DD6
author name string	Mandelli F Damasio E Visani G de Witte T Willemze R Labar B Papa G Leoni F Resegotti L Zittoun RA
rdfs:label	Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell'Ad (en) Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell'Ad (sq) Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. European Organization for Research and Treatment of Cancer (nl)
skos:prefLabel	Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell'Ad (en) Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell'Ad (sq) Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. European Organization for Research and Treatment of Cancer (nl)
name	Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell'Ad (en) Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell'Ad (sq) Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. European Organization for Research and Treatment of Cancer (nl)
title	wds:Q72377470-42F0717D-A1F9-4479-96E4-7E271B69B7BE
title	Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) Leukemia Cooperative Groups (en)
page(s)	wds:Q72377470-3BBC788D-9505-41EA-9A1D-6E7CAAE1E8AC
page(s)	217-223
instance of	wds:Q72377470-2D7567E6-865A-4B99-BD03-C05DDEDDA9E1
instance of	scholarly article
main subject	wds:Q72377470-BE6F172C-000D-43F9-B7B2-ABD4BAC1B876
main subject	chemotherapy
PubMed ID	wds:Q72377470-4A87086E-E73C-4F05-A81D-8B75C99DDC4E
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/7808487
PubMed ID	7808487
published in	wds:Q72377470-9321A707-D7DF-4697-AABE-F1823165A0D7
published in	The New England Journal of Medicine
issue	wds:Q72377470-60883975-F862-4777-BF5F-C5440B3B8CB2
volume	wds:Q72377470-D7701FC3-3715-4C5E-AB23-9326C13AF64E
issue	4
volume	332
DOI	wds:Q72377470-91910A31-4139-4301-81EE-038C97B65746
DOI	http://dx.doi.org/10.1056/NEJM199501263320403
DOI	10.1056/NEJM199501263320403
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q72377470
is cites work of	Acute myeloid leukaemia in adults Timed sequential therapy of acute myelogenous leukemia in adults: a phase II study of retinoids in combination with the sequential administration of cytosine arabinoside, idarubicin and etoposide High-dose cytosine arabinoside in the treatment of acute myeloid leukaemia The dismal outcome in patients with acute leukaemia who relapse after an autograft is improved if a second autograft or a matched allograft is performed. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT) Autologous blood cell vs marrow transplantation for acute myeloid leukemia in complete remission: an EBMT retrospective analysis High-dose treatment with autologous bone marrow support as consolidation of first remission in younger patients with acute myelogenous leukaemia The increase from 2.5 to 5 mg/kg of rabbit anti-thymocyte-globulin dose in reduced intensity conditioning reduces acute and chronic GVHD for patients with myeloid malignancies undergoing allo-SCT High-dose cytarabine in acute myeloid leukemia treatment: a systematic review and meta-analysis Delayed stem cell transplantation for the management of relapsed or refractory multiple myeloma Long-term outcome and quality of life of patients who are alive and in complete remission more than two years after allogeneic and syngeneic stem cell transplantation Randomised comparison of addition of autologous bone-marrow transplantation to intensive chemotherapy for acute myeloid leukaemia in first remission: results of MRC AML 10 trial. UK Medical Research Council Adult and Children's Leukaemia Working Par Efficacy of allogeneic hematopoietic stem cell transplantation depends on cytogenetic risk for acute myeloid leukemia in first disease remission: a metaanalysis Long-term outcome after allogeneic hematopoietic stem cell transplantation for advanced stage acute myeloblastic leukemia: a retrospective study of 379 patients reported to the Société Française de Greffe de Moelle (SFGM). The treatment of acute leukaemia Autologous bone marrow transplantation for acute myeloid leukemia in remission or first relapse using monoclonal antibody-purged marrow: results of phase II studies with long-term follow-up Roquinimex (Linomide) vs placebo in AML after autologous bone marrow transplantation Review of the Results of WT1 Peptide Vaccination Strategies for Myelodysplastic Syndromes and Acute Myeloid Leukemia from Nine Different Studies A randomized trial of amifostine in patients with high-dose VIC chemotherapy plus autologous blood stem cell transplantation Increasing use of reduced intensity conditioning transplants: report of the 2001 EBMT activity survey Internalization and cell cycle-dependent killing of leukemic cells by Gemtuzumab Ozogamicin: rationale for efficacy in CD33-negative malignancies with endocytic capacity Receptor for hyaluronan acid-mediated motility (RHAMM) is a new immunogenic leukemia-associated antigen in acute and chronic myeloid leukemia Immune reconstitution after autologous peripheral blood progenitor cell transplantation: effect of interleukin-15 on T-cell survival and effector functions Hematopoietic stem cell transplantation activity in Europe 1999 Granulocyte-macrophage colony-stimulating factor (GM-CSF)-secreting cellular immunotherapy in combination with autologous stem cell transplantation (ASCT) as postremission therapy for acute myeloid leukemia (AML). Minor histocompatibility antigens in human stem cell transplantation The effects of idarubicin versus other anthracyclines for induction therapy of patients with newly diagnosed leukaemia The kinetics of reduction of minimal residual disease impacts on duration of response and survival of patients with acute myeloid leukemia Hematopoietic stem cell transplantation for leukemia Immunomodulation in the treatment of haematological malignancies T-cell-replete haploidentical transplantation versus autologous stem cell transplantation in adult acute leukemia: a matched pair analysis Therapeutic advances in leukemia and myelodysplastic syndrome over the past 40 years Risk-adapted postremission therapy in acute myeloid leukemia: results of the German multicenter AML HD93 treatment trial The stem cell mobilizing capacity of patients with acute myeloid leukemia in complete remission correlates with relapse risk: results of the EORTC-GIMEMA AML-10 trial The role of bone marrow transplantation in acute promyelocytic leukemia Immature reticulocytes as an early predictor of engraftment in autologous and allogeneic bone marrow transplantation Humoral immunity to viral and bacterial antigens in lymphoma patients 4-10 years after high-dose therapy with ABMT. Serological responses to revaccinations according to EBMT guidelines. Prognostic factors in children and adolescents with acute myeloid leukemia (excluding children with Down syndrome and acute promyelocytic leukemia): univariate and recursive partitioning analysis of patients treated on Pediatric Oncology Group (POG) Assessment of quality of life during intensive chemotherapy or bone marrow transplantation. 131I-anti-CD45 antibody plus busulfan and cyclophosphamide before allogeneic hematopoietic cell transplantation for treatment of acute myeloid leukemia in first remission.

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 172 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software